Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Current Assets: 2016-2025

Historic Current Assets for Collegium Pharmaceutical (COLL) over the last 10 years, with Sep 2025 value amounting to $613.9 million.

  • Collegium Pharmaceutical's Current Assets rose 38.32% to $613.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $613.9 million, marking a year-over-year increase of 38.32%. This contributed to the annual value of $482.3 million for FY2024, which is 10.29% down from last year.
  • Collegium Pharmaceutical's Current Assets amounted to $613.9 million in Q3 2025, which was up 11.77% from $549.2 million recorded in Q2 2025.
  • Collegium Pharmaceutical's Current Assets' 5-year high stood at $613.9 million during Q3 2025, with a 5-year trough of $296.3 million in Q1 2021.
  • Its 3-year average for Current Assets is $525.1 million, with a median of $537.1 million in 2023.
  • In the last 5 years, Collegium Pharmaceutical's Current Assets skyrocketed by 38.57% in 2021 and then declined by 17.37% in 2024.
  • Collegium Pharmaceutical's Current Assets (Quarterly) stood at $315.5 million in 2021, then soared by 33.10% to $420.0 million in 2022, then grew by 28.00% to $537.6 million in 2023, then decreased by 10.29% to $482.3 million in 2024, then surged by 38.32% to $613.9 million in 2025.
  • Its Current Assets stands at $613.9 million for Q3 2025, versus $549.2 million for Q2 2025 and $527.6 million for Q1 2025.